Skip to main content

Table 2 Evaluation of the secondary outcomes by between-group analyses

From: Parsplana vitrectomy alone versus parsplana vitrectomy combined with phacoemulsification for the treatment of rhegmatogenous retinal detachment: a randomized study

Secondary outcomes

Group

Time-points

Week 1

mean ± s.d.

Month 1

mean ± s.d.

Month 3

mean ± s.d.

Month 6

mean ± s.d.

BVCA (logMAR)

A

0.50 ± 0.51

0.26 ± 0.16

0.20 ± 0.21

0.19 ± 0.18

B

0.55 ± 0.32

0.37 ± 0.26

0.31 ± 0.24

0.28 ± 0.23

p-value

n.s.

n.s.

n.s.

n.s.

IOP (mmHg)

A

17.7 ± 7.0

16.1 ± 2.4

15.9 ± 3.0

15.5 ± 2.6

B

13.7 ± 3.3

15.4 ± 4.9

14.9 ± 3.3

14.2 ± 3.5

p-value

< 0.001

n.s.

n.s.

n.s.

CMT (μm)

A

–

279 ± 26

270 ± 26

270 ± 25

B

–

278 ± 30

316 ± 118

297 ± 91

p-value

–

n.s.

0.01

n.s.

LOCS III

A

0.35 ± 0.75

0.54 ± 0.90

0.73 ± 1.15

1.31 ± 1.74

p-value

vs baseline

n.s

n.s

n.s

0.003

  1. BCVA Best-corrected visual acuity, IOP Intraocular pressure, CMT Central macular thickness (by Optical Coherence Tomography), LOCS III Lens Opacities Classification System III scale
Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us